Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Lombroso, , Benedetto,
DOB: 07-MAY-1989 (Age: 36)
Gender: male
Address:
Stretto Zaccagnini, 924
37121 Verona (Italy)
ID: 9244-804304-9 (ECI)
Report
Date: 05-MAR-2017
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Ospedale Civile Maggiore
Piazzale Aristide Stefani 1
37124 Verona (Italy)
Specimen
Collected: 05-MAR-2017

Chemistry

Test 05-MAR-2017 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.2 H 4 - 6 %
Glucose [Mass/volume] in Blood 69.4 L 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Blood 17.0 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 1.7 H 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 10.1 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 141.5 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.0 3.5 - 5.2 mmol/L
Chloride [Moles/volume] in Blood 106.0 98 - 114 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 24.1 24 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 158.4 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 148.2 40 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 101.3 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 27.5 L 40 - 100 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows mildly elevated HbA1c, suggesting impaired glucose regulation or early diabetes, despite a slightly low fasting glucose. Elevated creatinine may indicate reduced kidney function. HDL cholesterol is low, increasing cardiovascular risk. Other parameters are within normal limits. Recommend further evaluation of glycemic control, renal function, and lipid management.